S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL - N. Russell; C. Wilhelm-Benartzi; S. Knapper; L. Batten; J Canham; E. Hinson; U. Malthe Overgaard; J. Othman; R. Dillon; P. Mehta; P. Kottaridis; J. Cavenagh; et al. (HemaSphere, 2022)